423
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Characterization of pulmonary responses in mice to asbestos/asbestiform fibers using gene expression profiles

, , , , &

References

  • Albrecht, C., P. J. Borm, and K. Unfried. 2004. Signal transduction pathways relevant for neoplastic effects of fibrous and non-fibrous particles. Mutat. Res. 553:23–35.
  • Aldinucci, D., and A. Colombatti. 2014. The inflammatory chemokine ccl5 and cancer progression. Mediat. Inflamm. 2014:292376.
  • Aljandali, A., H. Pollack, A. Yeldandi, Y. Li, S. A. Weitzman, and D. W. Kamp. 2001. Asbestos causes apoptosis in alveolar epithelial cells: Role of iron-induced free radicals. J. Lab. Clin. Med. 137:330–339.
  • Andujar, P., A. Lacourt, P. Brochard, J. C. Pairon, M. C. Jaurand, and D. Jean. 2016. Five years update on relationships between malignant pleural mesothelioma and exposure to asbestos and other elongated mineral particles. J. Toxicol. Environ. Health. B 19:151–172.
  • Bernstein, D., V. Castranova, K. Donaldson, B. Fubini, J. Hadley, T. Hesterberg, A. Kane, D. Lai, E. E. McConnell, H. Muhle, G. Oberdorster, S. Olin, and D. B. Warheit; IlSI Risk Science Institute Working Group. 2005. Testing of fibrous particles: Short-term assays and strategies. Inhal. Toxicol. 17:497–537.
  • Boulanger, G., P. Andujar, J. C. Pairon, M. A. Billon-Galland, C. Dion, P. Dumortier, P. Brochard, A. Sobaszek, P. Bartsch, C. Paris, and M. C. Jaurand. 2014. Quantification of short and long asbestos fibers to assess asbestos exposure: A review of fiber size toxicity. Environ. Health 13:59.
  • Brazma, A., P. Hingamp, J. Quackenbush, G. Sherlock, P. Spellman, C. Stoeckert, J. Aach, W. Ansorge, C. A. Ball, H. C. Causton, T. Gaasterland, P. Glenisson, F. C. Holstege, I. F. Kim, V. Markowitz, J. C. Matese, H. Parkinson, A. Robinson, U. Sarkans, S. Schulze-Kremer, J. Stewart, R. Taylor, J. Vilo, and M. Vingron. 2001. Minimum information about a microarray experiment (miame)-toward standards for microarray data. Nat. Genet. 29:365–371.
  • Brown, R. C., R. Davies, and A. P. Rood. 1989. Modification of fibrous Oregon erionite and its effects on in vitro activity. IARC Sci. Publ. 90:74–80.
  • Cambelova, M., and A. Juck. 1994. Fibrogenic effect of wollastonite compared with asbestos dust and dusts containing quartz. Occup Environ Med 51:343–346.
  • Carbone, M., Y. I. Baris, P. Bertino, B. Brass, S. Comertpay, A. U. Dogan, G. Gaudino, S. Jube, S. Kanodia, C. R. Partridge, H. I. Pass, Z. S. Rivera, I. Steele, M. Tuncer, S. Way, H. Yang, and A. Miller. 2011. Erionite exposure in North Dakota and Turkish villages with mesothelioma. Proc. Natl. Acad. Sci. USA 108:13618–13623.
  • Carbone, M., R. A. Kratzke, and J. R. Testa. 2002. The pathogenesis of mesothelioma. Semin. Oncol. 29:2–17.
  • Carbone, M., H. I. Pass, P. Rizzo, M. Marinetti, M. Di Muzio, D. J. Mew, A. S. Levine, and A. Procopio. 1994. Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene 9:1781–1790.
  • Carbone, M., and H. Yang. 2012. Molecular pathways: Targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma. Clin. Cancer Res. 18:598–604.
  • Churg, A. 1996. The uptake of mineral particles by pulmonary epithelial cells. Am. J. Respir. Crit. Care Med. 154:1124–1140.
  • Clutterbuck, E. J., E. M. Hirst, and C. J. Sanderson. 1989. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: Comparison and interaction with IL-1, IL-3, IL-6, and GMCSF. Blood 73:1504–1512.
  • Comar, M., N. Zanotta, G. Pesel, P. Visconti, I. Maestri, R. Rinaldi, S. Crovella, M. Cortale, R. De Zotti, and M. Bovenzi. 2012. Asbestos and SV40 in malignant pleural mesothelioma from a hyperendemic area of north-eastern Italy. Tumori 98:210–214.
  • Cyphert, J. M., M. A. McGee, A. Nyska, M. C. Schladweiler, U. P. Kodavanti, and S. H. Gavett. 2016. Long-term toxicity of naturally occurring asbestos in male Fischer 344 rats. J. Toxicol. Environ. Health A 79:49–60.
  • Cyphert, J. M., A. Nyska, R. K. Mahoney, M. C. Schladweiler, U. P. Kodavanti, and S. H. Gavett. 2012. Sumas mountain chrysotile induces greater lung fibrosis in Fischer344 rats than Libby amphibole, El Dorado tremolite, and Ontario ferroactinolite. Toxicol. Sci. 130:405–415.
  • Dodson, R. F. 2016. Preface: Respirable elongated mineral particles and human health-revisited. J. Toxicol. Environ. Health B 19:149–150.
  • Dogan, A. U., Y. I. Baris, M. Dogan, S. Emri, I. Steele, A. G. Elmishad, and M. Carbone. 2006. Genetic predisposition to fiber carcinogenesis causes a mesothelioma epidemic in Turkey. Cancer Res. 66:5063–5068.
  • Donaldson, K., B. G. Miller, E. Sara, J. Slight, and R. C. Brown. 1993. Asbestos fibre length-dependent detachment injury to alveolar epithelial cells in vitro: Role of a fibronectin-binding receptor. Int. J. Exp. Pathol. 74:243–250.
  • Donaldson, K., F. A. Murphy, R. Duffin, and C. A. Poland. 2010. Asbestos, carbon nanotubes and the pleural mesothelium: A review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol. 7:5– 5.
  • Doucet, C., D. Brouty-Boye, C. Pottin-Clemenceau, G. W. Canonica, C. Jasmin, and B. Azzarone. 1998. Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. J. Clin. Invest. 101:2129–2139.
  • Emad, A., and V. Emad. 2007. Elevated levels of MCP-1, MIP-alpha and MIP-1 beta in the bronchoalveolar lavage (BAL) fluid of patients with mustard gas-induced pulmonary fibrosis. Toxicology 240:60–69.
  • Everitt, B. S., S. Landau, M. Leese, and D. Stahl. 2011. Hierarchical clustering. In David, J. Balding, Noel, A.C.Cressie, Garrett, M. Fitzmaurice, Harvey Goldstein, Geert Molenberghs, David, W. Scott, Adrian F.M.Smith, Ruey S.Tsay, Sanford Weisberg (eds.). Cluster analysis, 71–110. John Wiley & Sons, Ltd. https://pdfs.semanticscholar.org/b05a/ca28ced3751d6302d8ce7396f80c90d612fd.pdf
  • Fach, E., R. Kristovich, J. F. Long, W. J. Waldman, P. K. Dutta, and M. V. Williams. 2003. The effect of iron on the biological activities of erionite and mordenite. Environ. Int. 29:451–458.
  • Frost, G., A. Darnton, and A. H. Harding. 2011. The effect of smoking on the risk of lung cancer mortality for asbestos workers in great britain (1971-2005). Ann. Occup. Hyg. 55:239–247.
  • Fubini, B., and I. Fenoglio. 2007. Toxic potential of mineral dusts. Elements 3:407.
  • Gandolfi, N. B., A. F. Gualtieri, S. Pollastri, E. Tibaldi, and F. Belpoggi. 2016. Assessment of asbestos body formation by high resolution feg-sem after exposure of Sprague-Dawley rats to chrysotile, crocidolite, or erionite. J. Hazard. Mater. 306:95–104.
  • Gasse, P., C. Mary, I. Guenon, N. Noulin, S. Charron, S. Schnyder-Candrian, B. Schnyder, S. Akira, V. F. Quesniaux, V. Lagente, B. Ryffel, and I. Couillin. 2007. Il-1r1/myd88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice. J. Clin. Invest. 117:3786–3799.
  • Gavett, S. H., C. U. Parkinson, G. A. Willson, C. E. Wood, A. M. Jarabek, K. C. Roberts, U. P. Kodavanti, and D. E. Dodd. 2016. Persistent effects of libby amphibole and amosite asbestos following subchronic inhalation in rats. Part Fibre Toxicol. 13:17.
  • Gharaee-Kermani, M., Y. Nozaki, K. Hatano, and S. H. Phan. 2001. Lung interleukin-4 gene expression in a murine model of bleomycin-induced pulmonary fibrosis. Cytokine 15:138–147.
  • Ghio, A., R. J. Tan, K. Ghio, C. L. Fattman, and T. D. Oury. 2009. Iron accumulation and expression of iron-related proteins following murine exposure to crocidolite. J. Environ. Pathol. Toxicol. Oncol. 28:153–162.
  • Ghio, A. J. 2009. Disruption of iron homeostasis and lung disease. Biochim. Biophys. Acta. 1790:731–739.
  • Goodglick, L. A., and A. B. Kane. 1986. Role of reactive oxygen metabolites in crocidolite asbestos toxicity to mouse macrophages. Cancer Res. 46:5558–5566.
  • Governa, M., L. Camilucci, M. Amati, I. Visona, M. Valentino, G. C. Botta, A. Campopiano, and C. Fanizza. 1998. Wollastonite fibers in vitro generate reactive oxygen species able to lyse erythrocytes and activate the complement alternate pathway. Toxicol. Sci. 44:32–38.
  • Gualtieri, A. F., N. Bursi Gandolfi, S. Pollastri, M. Burghammer, E. Tibaldi, F. Belpoggi, K. Pollok, F. Langenhorst, R. Vigliaturo, and G. Drazic. 2017. New insights into the toxicity of mineral fibres: A combined in situ synchrotron MU-XRD and HR-TEM study of chrysotile, crocidolite, and erionite fibres found in the tissues of Sprague-Dawley rats. Toxicol. Lett. 274:20–30.
  • Harper, M., B. Van Gosen, O. S. Crankshaw, S. S. Doorn, T. J. Ennis, and S. E. Harrison. 2015. Characterization of lone pine, California, tremolite asbestos and preparation of research material. Ann. Occup. Hyg. 59:91–103.
  • Hillegass, J. M., A. Shukla, S. A. Lathrop, M. B. MacPherson, S. L. Beuschel, K. J. Butnor, J. R. Testa, H. I. Pass, M. Carbone, C. Steele, and B. T. Mossman. 2010. Inflammation precedes the development of human malignant mesotheliomas in a SCID mouse xenograft model. Ann. N Y Acad. Sci. 1203:7–14.
  • Kamp, D. W., E. Shacter, and S. A. Weitzman. 2011. Chronic inflammation and cancer: The role of the mitochondria. Oncology 25 (400–410):413.
  • Kane, A. B. 1996. Mechanisms of mineral fibre carcinogenesis. IARC Sci. Publ. 11–34.
  • Kuleshov, M. V., M. R. Jones, A. D. Rouillard, N. F. Fernandez, Q. Duan, Z. Wang, S. Koplev, S. L. Jenkins, K. M. Jagodnik, A. Lachmann, M. G. McDermott, C. D. Monteiro, G. W. Gundersen, and A. Ma’ayan. 2016. Enrichr: A comprehensive gene set enrichment analysis web server 2016 update. Nucl. Acids. Res. 44:W90–W97.
  • LaDou, J., B. Castleman, A. Frank, M. Gochfeld, M. Greenberg, J. Huff, T. K. Joshi, P. J. Landrigan, R. Lemen, J. Myers, M. Soffritti, C. L. Soskolne, K. Takahashi, D. Teitelbaum, B. Terracini, and A. Watterson. 2010. The case for a global ban on asbestos. Environ. Health Persp. 118:897–901.
  • Lemen, R. A. 2016. Mesothelioma from asbestos exposures: Epidemiologic patterns and impact in the united states. J. Toxicol. Environ. Health B 19:250–265.
  • Li, W. 2012. Volcano plots in analyzing differential expressions with mrna microarrays. J. Bioinform. Comput. Biol. 10:1231003.
  • Lowers, H., and G. Meeker. 2002. Tabulation of asbestos-related terminology. In Open-file report (Report 02-458). U.S. geological survey., Version 1.0. http://pubs.er.usgs.gov/publication/ofr02458.
  • Lowers, H. A., D. T. Adams, G. P. Meeker, and C. J. Nutt. 2010. Chemical and morphological comparison of erionite from Oregon, North Dakota, and Turkey. Reston, VA: Environmental Protection Agency, Denver, CO. Region VIII.; Geological Survey.
  • Mastruzzo, C., N. Crimi, and C. Vancheri. 2002. Role of oxidative stress in pulmonary fibrosis. Monaldi Arch. Chest. Dis. 57:173–176.
  • Maxim, L. D., and E. E. McConnell. 2005. A review of the toxicology and epidemiology of wollastonite. Inhal. Toxicol. 17:451–466.
  • McConnell, E. E., L. Hall, and B. Adkins. 1991. Studies on the chronic toxicity (inhalation) of wollastonite in fischer 344 rats. Inhal. Toxicol. 3:323–337.
  • Moller, P., P. H. Danielsen, D. G. Karottki, K. Jantzen, M. Roursgaard, H. Klingberg, D. M. Jensen, D. V. Christophersen, J. G. Hemmingsen, Y. Cao, and S. Loft. 2014. Oxidative stress and inflammation generated DNA damage by exposure to air pollution particles. Mutat. Res. Rev. Mutat. Res. 762:133–166.
  • Mossman, B. T., and A. Churg. 1998. Mechanisms in the pathogenesis of asbestosis and silicosis. Am. J. Respir. Crit. Care Med. 157:1666–1680.
  • Mossman, B. T., and J. P. Marsh. 1989. Evidence supporting a role for active oxygen species in asbestos-induced toxicity and lung disease. Environ. Health Persp. 81:91–94.
  • Murray, A. R., E. R. Kisin, A. V. Tkach, N. Yanamala, R. Mercer, S. H. Young, B. Fadeel, V. E. Kagan, and A. A. Shvedova. 2012. Factoring-in agglomeration of carbon nanotubes and nanofibers for better prediction of their toxicity versus asbestos. Part Fibre Toxicol. 9:10.
  • Murtagh, F., and P. Legendre. 2014. Ward’s hierarchical agglomerative clustering method: Which algorithms implement ward’s criterion? J. Classif. 31:274–295.
  • National Research Council (U.S.). Committee on Nonoccupational Health Risks of Asbestiform Fibers. 1984. Asbestiform fibers: Nonoccupational health risks. Washington, D.C.: National Academy Press.
  • Ndlovu, N., D. Rees, J. Murray, N. Vorajee, G. Richards, and J. teWaterNaude. 2017. Asbestos-related diseases in mineworkers: A clinicopathological study. ERJ Open Res. 3. http://openres.ersjournals.com/content/erjor/3/3/00022-2017.full.pdf
  • Noonan, C. W., J. C. Pfau, T. C. Larson, and M. R. Spence. 2006. Nested case-control study of autoimmune disease in an asbestos-exposed population. Environ. Health Persp. 114:1243–1247.
  • NTP. 2016. Asbestos. In Report on carcinogens, 14th ed. Research Triangle Park, NC: U.S. Department of Health and Human Services, Public Health Service. http://ntp.niehs.nih.gov/go/roc14/.
  • Nymark, P., P. M. Lindholm, M. V. Korpela, L. Lahti, S. Ruosaari, S. Kaski, J. Hollmen, S. Anttila, V. L. Kinnula, and S. Knuutila. 2007. Gene expression profiles in asbestos-exposed epithelial and mesothelial lung cell lines. BMC Genomics. 8:62.
  • O’Reilly, K. M., A. M. McLaughlin, W. S. Beckett, and P. J. Sime. 2007. Asbestos-related lung disease. Am. Family Physician. 75:683–688.
  • Oberdorster, G. 1996. Evaluation and use of animal models to assess mechanisms of fibre carcinogenicity. IARC Sci. Publ. 140:107–125.
  • Ogushi, F. 1996. The role of cytokines in pulmonary fibrosis. Nihon Ika Daigaku Zasshi 63:391–394.
  • Palekar, L. D., J. F. Eyre, B. M. Most, and D. L. Coffin. 1987. Metaphase and anaphase analysis of v79 cells exposed to erionite, UICC chrysotile and UICC crocidolite. Carcinogenesis 8:553–560.
  • Palekar, L. D., B. M. Most, and D. L. Coffin. 1988. Significance of mass and number of fibers in the correlation of V79 cytotoxicity with tumorigenic potential of mineral fibers. Environ. Res. 46:142–152.
  • Pascolo, L., G. Zabucchi, A. Gianoncelli, G. Kourousias, E. Trevisan, E. Pascotto, C. Casarsa, C. Ryan, M. Lucattelli, G. Lungarella, E. Cavarra, B. Bartalesi, M. Zweyer, F. Cammisuli, M. Melato, and V. Borelli. 2016. Synchrotron x-ray microscopy reveals early calcium and iron interaction with crocidolite fibers in the lung of exposed mice. Toxicol. Lett. 241:111–120.
  • Pfau, J. C., K. M. Serve, and C. W. Noonan. 2014. Autoimmunity and asbestos exposure. Autoimmune. Dis. 2014:782045.
  • Pinkerton, K. E., S. L. Young, E. K. Fram, and J. D. Crapo. 1990. Alveolar type ii cell responses to chronic inhalation of chrysotile asbestos in rats. Am. J. Respir. Cell. Mol. Biol. 3:543–552.
  • Poland, C. A., R. Duffin, I. Kinloch, A. Maynard, W. A. Wallace, A. Seaton, V. Stone, S. Brown, W. Macnee, and K. Donaldson. 2008. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat. Nanotechnol. 3:423–428.
  • Pollastri, S., A. F. Gualtieri, R. Vigliaturo, K. Ignatyev, E. Strafella, A. Pugnaloni, and A. Croce. 2016. Stability of mineral fibres in contact with human cell cultures. An in situ muxanes, muxrd and xrf iron mapping study. Chemosphere 164:547–557.
  • Quinlan, T. R., K. A. BeruBe, J. P. Marsh, Y. M. Janssen, P. Taishi, K. O. Leslie, D. Hemenway, P. T. O’Shaughnessy, P. Vacek, and B. T. Mossman. 1995. Patterns of inflammation, cell proliferation, and related gene expression in lung after inhalation of chrysotile asbestos. Am. J. Pathol. 147:728–739.
  • R Development Core Team. (2010). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL. http://www.R-project.org/.
  • Ramos-Nino, M. E., C. R. Timblin, and B. T. Mossman. 2002. Mesothelial cell transformation requires increased AP-1 binding activity and ERK-dependent FRA-1 expression. Cancer Res. 62:6065–6069.
  • Rao, G. V., S. Tinkle, D. N. Weissman, J. M. Antonini, M. L. Kashon, R. Salmen, L. A. Battelli, P. A. Willard, M. D. Hoover, and A. F. Hubbs. 2003. Efficacy of a technique for exposing the mouse lung to particles aspirated from the pharynx. J. Toxicol. Environ. Health A 66:1441–1452.
  • Roe, O. D., E. Anderssen, E. Helge, C. H. Pettersen, K. S. Olsen, H. Sandeck, R. Haaverstad, S. Lundgren, and E. Larsson. 2009. Genome-wide profile of pleural mesothelioma versus parietal and visceral pleura: The emerging gene portrait of the mesothelioma phenotype. PLoS One 4:e6554.
  • Rola-Pleszczynski, M., S. Gouin, and R. Begin. 1984. Asbestos-induced lung inflammation. Role of local macrophage-derived chemotactic factors in accumulation of neutrophils in the lungs. Inflammation 8:53–62.
  • Sanchez, V. C., J. R. Pietruska, N. R. Miselis, R. H. Hurt, and A. B. Kane. 2009. Biopersistence and potential adverse health impacts of fibrous nanomaterials: What have we learned from asbestos? Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1:511–529.
  • Sayan, M., and B. T. Mossman. 2016. The nlrp3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases. Part Fibre Toxicol. 13:51.
  • Searl, A., D. Buchanan, R. T. Cullen, A. D. Jones, B. G. Miller, and C. A. Soutar. 1999. Biopersistence and durability of nine mineral fibre types in rat lungs over 12 months. Ann. Occup. Hyg. 43:143–153.
  • Shatos, M. A., J. M. Doherty, J. P. Marsh, and B. T. Mossman. 1987. Prevention of asbestos-induced cell death in rat lung fibroblasts and alveolar macrophages by scavengers of active oxygen species. Environ. Res. 44:103–116.
  • Shukla, A., J. M. Miller, C. Cason, M. Sayan, M. B. MacPherson, S. L. Beuschel, J. Hillegass, P. M. Vacek, H. I. Pass, and B. T. Mossman. 2013. Extracellular signal-regulated kinase 5: A potential therapeutic target for malignant mesotheliomas. Clin. Cancer Res. 19:2071–2083.
  • Singh, A., N. Pruett, and C. D. Hoang. 2017. In vitro experimental models of mesothelioma revisited. Transl. Lung Cancer Res. 6:248–258.
  • Tatrai, E., M. Brozik, Z. Kovacikova, and M. Horvath. 2005. The effect of asbestos and stone-wool fibres on some chemokines and redox system of pulmonary alveolar macrophages and pneumocytes type II. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 149:357–361.
  • Trevisan, E., G. Zabucchi, L. Pascolo, E. Pascotto, C. Casarsa, M. Lucattelli, G. Lungarella, E. Cavarra, B. Bartalesi, M. Zweyer, and V. Borelli. 2016. Histopathological data of iron and calcium in the mouse lung after asbestos exposure. Data Brief 6:769–775.
  • Wagner, J. C., J. W. Skidmore, R. J. Hill, and D. M. Griffiths. 1985. Erionite exposure and mesotheliomas in rats. Br. J. Cancer 51:727–730.
  • Ward, J. H. 1963. Hierarchical grouping to optimize an objective function. J. Am. Stat. Assoc. 58:236–244.
  • Wild, P. 2006. Lung cancer risk and talc not containing asbestiform fibres: A review of the epidemiological evidence. Occup. Environ. Med. 63:4–9.
  • Williams, P. R., A. D. Phelka, and D. J. Paustenbach. 2007. A review of historical exposures to asbestos among skilled craftsmen (1940-2006). J. Toxicol. Environ. Health B. 10:319–377.
  • Wylie, A. G., and P. A. Candela. 2015. Methodologies for determining the sources, characteristics, distribution, and abundance of asbestiform and nonasbestiform amphibole and serpentine in ambient air and water. J. Toxicol. Environ. Health B. 18:1–42.
  • Wynn, T. A. 2008. Cellular and molecular mechanisms of fibrosis. J. Pathol. 214:199–210.
  • Zabeau, L., P. Gevaert, C. Bachert, and J. Tavernier. 2003. Interleukin-5, eosinophilic diseases and therapeutic intervention. Curr. Drug Targets Inflamm. Allergy. 2:319–328.
  • Zhang, K., and S. H. Phan. 1996. Cytokines and pulmonary fibrosis. Biol. Sig. 5:232–239.
  • Zhu, Z., R. J. Homer, Z. Wang, Q. Chen, G. P. Geba, J. Wang, Y. Zhang, and J. A. Elias. 1999. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103:779–788.
  • Zurawski, G., and J. E. De Vries. 1994. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and b cells, but not on t cells. Immunol. Today 15:19–26.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.